Fady Ibraham Malik

Companies

• Rocket Pharmaceuticals Inc.Board member Mar 11, 2022 to now¹
• CytokineticsSVP Research & Early Dev Jun 8, 2012 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CCytokinetics CYTK153,902 shares³$9.5M at $61.95Sep 22, 2026
• RPRocket Pharmaceuticals Inc. RCKT52,862 shares⁴$124.8K at $2.36Jun 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 22, 2026Sold 3,500 shares at $68.29 of Cytokinetics³
• Sep 22, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics³
• Sep 8, 2026Sold 3,500 shares at $75.46 of Cytokinetics⁵
• Sep 8, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics⁵
• Aug 18, 2026Sold 3,500 shares at $75.82 of Cytokinetics⁶
• Aug 18, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics⁶
• Jul 21, 2026Sold 3,500 shares at $80.59 of Cytokinetics⁷
• Jul 21, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics⁷
• Jul 7, 2026Sold 3,500 shares at $86.62 of Cytokinetics⁸
• Jul 7, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics⁸
• Jun 23, 2026Sold 3,500 shares at $79.51 of Cytokinetics⁹
• Jun 23, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics⁹
• Jun 18, 2026Granted 22,862 shares of Rocket Pharmaceuticals Inc.⁴
• Jun 9, 2026Sold 3,500 shares at $67.98 of Cytokinetics¹⁰
• Jun 9, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics¹⁰
• May 19, 2026Sold 3,500 shares at $75.69 of Cytokinetics¹¹
• May 19, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics¹¹
• May 5, 2026Sold 3,500 shares at $77.37 of Cytokinetics¹²
• May 5, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics¹²
• Apr 21, 2026Sold 3,500 shares at $65.69 of Cytokinetics¹³
• Apr 21, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics¹³
• Apr 7, 2026Sold 1,000 shares at $64.75 of Cytokinetics¹⁴
• Apr 7, 2026Exercised options 1,000 shares at $10.60 of Cytokinetics¹⁴
• Apr 7, 2026Sold 3,500 shares at $65.21 of Cytokinetics¹⁴
• Apr 7, 2026Exercised options 3,500 shares at $7.80 of Cytokinetics¹⁴